OPTZ
Optimize Strategy Index ETF
Optimize Strategy Index ETF seeks to provide long-term capital appreciation by investing in a diversified portfolio that adapts to changing market conditions through a systematic, rules-based approach.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 279.4 M
ASSETS UNDER MGMT
50 bp
EXPENSES
Fund Basics
| Inception date | Apr 22, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| SANDISK CORP | 3.9 % |
| PENGUIN SOLUTIONS INC | 3.4 % |
| MICRON TECHNOLOGY INC | 3.0 % |
| ADVANCED MICRO DEVICES | 2.7 % |
| SEAGATE TECHNOLOGY HOLDINGS PLC | 2.5 % |
| WESTERN DIGITAL CORP | 2.4 % |
| TTM TECHNOLOGIES | 2.2 % |
| APPLIED MATERIALS INC | 1.9 % |
| LAM RESEARCH CORP | 1.9 % |
| KLA CORPORATION | 1.8 % |
Constituent Breakdown
| Number of holdings | 333 |
| Herfindahl-Hirschman Index | 111 |
| Wgt avg mkt cap (mns) | $106,829 |
| Large cap (>$10bn) | 73.0% |
| Mid cap ($2-10bn) | 18.7% |
| Small cap (<$2bn) | 23.4% |
| Developed mkts. | 115.1% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 87.7 % |
 |
IRELAND | 4.7 % |
 |
BRITAIN | 1.8 % |
 |
CANADA | 1.1 % |
 |
CAYMAN ISLANDS | 1.1 % |
 |
BERMUDA | 0.6 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 27.3% | 57.9% | 31.2% | -- | -- | -- | -- | 32.6% |
| Dividend Yield | 0.0% | 0.9% | 0.6% | -- | -- | -- | -- | 0.6% |
| Total Returns | 27.3% | 58.8% | 31.8% | -- | -- | -- | -- | 33.2% | Ann. Volatility | 20.5% | 18.0% | 21.0% | -- | -- | -- | -- | 20.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.32 | 75% |
| MSCI EAFE | 0.87 | 52% |
| MSCI Emg Mkts | 0.67 | 55% |
Liquidity Measures
| Avg. volume (000) | 3 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.40% |
Technical Indicators
| 30d moving avg. (EMA) | $46.24 |
| Relative strength (RSI) | 60 |
| MACD/Signal | 1.15/1.20 |
| Bollinger Bands (Upper/Lower) | $49.73/$44.52 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. OPTZ |
Expenses vs. OPTZ |
ALTAR Score™ vs. OPTZ |
|---|---|---|---|---|
| FTC | First Trust Large Cap Growth AlphaDEX Fund | 30.8% | +9 bp | -1.2% |
| RSPT | Invesco S&P 500 Equal Weight Technology ETF | 29.6% | -10 bp | +0.5% |
| PWB | Invesco Large Cap Growth ETF | 28.2% | +6 bp | -0.9% |
| ALTL | Pacer Lunt Large Cap Alternator ETF | 28.0% | +10 bp | +1.1% |
| JMOM | JPMorgan U.S. Momentum Factor ETF | 27.8% | -38 bp | +0.2% |
| VEGN | US Vegan Climate ETF | 27.5% | +10 bp | +0.3% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 26.6% | -37 bp | -1.4% |
| JHML | John Hancock Multifactor Large Cap ETF | 26.0% | -21 bp | +1.4% |
| AVSU | Avantis Responsible U.S. Equity ETF | 25.9% | -35 bp | +1.8% |
| ROUS | Hartford Multifactor US Equity ETF | 25.7% | -31 bp | +2.4% |
Risk and Returns: OPTZ vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/30/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.6%
ALTAR SCORE™
21st
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,398 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. OPTZ's ALTAR Score™ is approximately -0.8 standard
deviations above the category average. This places OPTZ in the 21st percentile
among funds in the category.
Sell-Side Consensus
$47.58
PRICE TARGET
-2.3%
UPSIDE